Using steady‐state kinetic measurements of phenylalanine activation and tRNAPhe aminoacylation, we gained insight into the structural and kinetic effects of mitochondrial disease‐related mutations in FARS2 gene. The gene discussed is FARS2; the disease is inborn mitochondrial metabolism disorder.